Compositions and methods for production of myrcene
Provided herein are compositions and methods for producing myrcene by culturing genetically modified microbial host cells that express a myrcene synthase and optionally a geranyl pyrophosphate synthase. Also provided herein are isolated nucleic acid molecules that encode myrcene synthase variants derived from the Ocimum species myrcene synthase, which comprise one or more amino acid substitutions that improve in vivo performance of myrcene synthase in genetically modified microbial host cells. Also provided herein are isolated myrcene synthase variants that exhibit an improved activity for converting geranyl diphosphate into myrcene.
1. A fermentation composition comprising:
(a) a genetically modified microbial host cell cultured in a culture medium, wherein the microbial host cell comprises a heterologous nucleic acid molecule encoding a myrcene synthase, wherein the myrcene synthase comprises a sequence that has at least about 70% sequence identity to SEQ ID NO: 2, and at least one variant amino acid residue at position 27, 28, 207, 213, 222, 342, 347, 381, 382, 389, 390, 401, 404, 428, 439, 466, 482, 484, 505, 514, 517, 524, 527, 528, 543, 544, or 552, wherein the positions are numbered with reference to SEQ ID NO: 2; and
(b) monoterpenes produced from the microbial host cell, wherein the monoterpenes comprise myrcene as a major component and one or more co-products as minor components, wherein the one or more co-products comprise α-terpinene and γ-terpinene.
2. The fermentation composition of claim 1 , wherein the one or more co-products further comprise 4-terpineol.
3. The fermentation composition of claim 1 , wherein the one or more co-products further comprise sabinene, limonene, β-ocimene, or β-linalool.
4. The fermentation composition of claim 1 , wherein the one or more co-products further comprise α-thujene, (E)-sabinene hydrate, or (Z)-sabinene hydrate.
5. The fermentation composition of claim 1 , wherein the monoterpenes comprise at least about 85% myrcene and less than about 15% the one or more co-products, compared to the total amount of the monoterpenes.
6. The fermentation composition of claim 1 , wherein the monoterpenes comprise between about 88% to about 93% myrcene, compared to the total amount of the monoterpenes.
7. The fermentation composition of claim 1 , wherein the monoterpenes comprise between about 0.5% to about 1% α-terpinene, compared to the total amount of the monoterpenes.
8. The fermentation composition of claim 1 , wherein the monoterpenes comprise between about 0.5% to about 1.5% γ-terpinene, compared to the total amount of the monoterpenes.
9. The fermentation composition of claim 1 , wherein the monoterpenes comprise between about 1% to about 3% 4-terpineol, compared to the total amount of the monoterpenes.
10. The fermentation composition of claim 1 , wherein the monoterpenes comprise, based on the total amount of the monoterpenes: about 89.09% to about 92.01% myrcene, about 0.80% to about 0.98% sabinene, about 0.67% to about 0.90% α-terpinene, about 0.54% to about 1.01% limonene, about 0.91% to about 1.21% β-ocimene, about 1.00% to about 1.06% γ-terpinene, about 0.76% to about 1.17% β-linalool, and about 2.32% to about 2.42% 4-terpineol.
11. The fermentation composition of claim 10 , wherein the monoterpenes further comprise, based on the total amount of the monoterpenes: about 0% to about 0.51% α-thujene, about 0% to about 0.54% (E)-sabinene hydrate, and about 0.98% to about 1.13% (Z)-sabinene hydrate.
12. The fermentation composition of claim 1 , wherein the myrcene synthase exhibits an improved activity for converting geranyl diphosphate into myrcene compared to the activity of a myrcene synthase of SEQ ID NO: 2 under identical reaction conditions.
13. The fermentation composition of claim 1 , wherein the myrcene synthase exhibits an improved activity for converting geranyl diphosphate into myrcene compared to the activity of a myrcene synthase isolated from Quercus ilex, Abies grandis, Antirrhinum majus, Arabidopsis thaliana, Aegilops squarrosa, Alstroemeria peruviana or Picea abies under identical reaction conditions.
14. The fermentation composition of claim 1 , wherein the heterologous nucleic acid molecule encoding the myrcene synthase is a nucleic acid molecule encoding Ocimum basilicum myrcene synthase.
15. The fermentation composition of claim 1 , wherein the myrcene synthase comprises an amino acid sequence having at least about 75% sequence identity to SEQ ID NO: 2.
16. The fermentation composition of claim 1 , wherein the at least one variant amino acid residue is selected from the group consisting of H27I, H27C, S28H, 1207V, K213C, K213H, K213R, K213V, R222N, C342L, Y347R, F381L, V382L, D389G, D389S, G390D, N401I, N401V, 1404V, V428L, Y439L, A466C, A466S, R482C, R482D, R482H, R482I, R482L, R482N, R482V, H484Y, C505I, C505L, C505V, G514L, G514V, S517G, F524L, F524V, V527C, V527F, V527H, V527L, V527N, V527S, V527Y, E528D, M543I, A544S, and Q552R, wherein the positions are numbered with reference to SEQ ID NO: 2.
17. The fermentation composition of claim 16 , wherein the myrcene synthase comprises at least one set of variant amino acid residues compared to SEQ ID NO: 2, and wherein the at least one set of variant amino acid residues is selected from the group of sets of variant amino acid residues consisting of:
(a) F381L, 1404V, E528D, and M543I;
(b) 1404V and E528D;
(c) F381L, D389G, 1404V, Y439L, and E528D;
(d) F381L, E528D, and M543I;
(e) F381L, 1404V, and E528D;
(f) F381L, 1404V, E528D, and A544S; and
(g) F381L, 1404V, E528D, and Q552R,
wherein the positions are numbered with reference to SEQ ID NO: 2.
18. The fermentation composition of claim 17 , wherein the myrcene synthase comprises variant amino acid residues F381L, I404V, and E528D compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2.
19. A fermentation composition comprising:
(a) a genetically modified microbial host cell cultured in a culture medium, wherein the microbial host cell comprises a heterologous nucleic acid molecule encoding a myrcene synthase, wherein the myrcene synthase comprises a sequence that has at least about 70% sequence identity to SEQ ID NO: 2, and wherein the myrcene synthase comprises variant amino acid residues F381L, I404V, E528D, and A544S compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2;
(b) monoterpenes produced from the microbial host cell, wherein the monoterpenes comprise myrcene as a major component and one or more co-products as minor components, wherein the one or more co-products comprise α-terpinene and γ-terpinene.
20. A fermentation composition comprising:
(a) a genetically modified microbial host cell cultured in a culture medium, wherein the microbial host cell comprises a heterologous nucleic acid molecule encoding a myrcene synthase, wherein the myrcene synthase comprises a sequence that has at least about 70% sequence identity to SEQ ID NO: 2, and wherein the myrcene synthase comprises variant amino acid residues F381L, I404V, E528D, and Q552R compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2;
(b) monoterpenes produced from the microbial host cell, wherein the monoterpenes comprise myrcene as a major component and one or more co-products as minor components, wherein the one or more co-products comprise α-terpinene and γ-terpinene.
21. The fermentation composition of claim 1 , wherein the heterologous nucleic acid molecule encoding the myrcene synthase comprises a nucleotide sequence having at least about 70% SEQ ID NO: 1, SEQ ID NO: 3, or SEQ ID NO: 4.
22. The fermentation composition of claim 1 , wherein the myrcene synthase has 80% identity to SEQ ID NO: 2.
23. The fermentation composition of claim 1 , wherein the myrcene synthase has 90% identity to SEQ ID NO: 2.
24. The fermentation composition of claim 1 , wherein the myrcene synthase has 95% identity to SEQ ID NO: 2.